Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

141 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pilot trial of interleukin-2 and zoledronic acid to augment γδ T cells as treatment for patients with refractory renal cell carcinoma.
Lang JM, Kaikobad MR, Wallace M, Staab MJ, Horvath DL, Wilding G, Liu G, Eickhoff JC, McNeel DG, Malkovsky M. Lang JM, et al. Among authors: mcneel dg. Cancer Immunol Immunother. 2011 Oct;60(10):1447-60. doi: 10.1007/s00262-011-1049-8. Epub 2011 Jun 7. Cancer Immunol Immunother. 2011. PMID: 21647691 Free PMC article. Clinical Trial.
Immune-based therapies for prostate cancer.
McNeel DG, Malkovsky M. McNeel DG, et al. Immunol Lett. 2005 Jan 15;96(1):3-9. doi: 10.1016/j.imlet.2004.06.009. Immunol Lett. 2005. PMID: 15585302 Review.
Newer therapies in advanced prostate cancer.
Hegeman RB, Liu G, Wilding G, McNeel DG. Hegeman RB, et al. Among authors: mcneel dg. Clin Prostate Cancer. 2004 Dec;3(3):150-6. doi: 10.3816/cgc.2004.n.025. Clin Prostate Cancer. 2004. PMID: 15636681 Review.
Phase I trial of a monoclonal antibody specific for alphavbeta3 integrin (MEDI-522) in patients with advanced malignancies, including an assessment of effect on tumor perfusion.
McNeel DG, Eickhoff J, Lee FT, King DM, Alberti D, Thomas JP, Friedl A, Kolesar J, Marnocha R, Volkman J, Zhang J, Hammershaimb L, Zwiebel JA, Wilding G. McNeel DG, et al. Clin Cancer Res. 2005 Nov 1;11(21):7851-60. doi: 10.1158/1078-0432.CCR-05-0262. Clin Cancer Res. 2005. PMID: 16278408 Clinical Trial.
Endothelin receptor antagonists in cancer therapy.
Lalich M, McNeel DG, Wilding G, Liu G. Lalich M, et al. Among authors: mcneel dg. Cancer Invest. 2007 Dec;25(8):785-94. doi: 10.1080/07357900701522588. Cancer Invest. 2007. PMID: 18058475 Review.
Randomized, double-blinded phase II evaluation of docetaxel with or without doxercalciferol in patients with metastatic, androgen-independent prostate cancer.
Attia S, Eickhoff J, Wilding G, McNeel D, Blank J, Ahuja H, Jumonville A, Eastman M, Shevrin D, Glode M, Alberti D, Staab MJ, Horvath D, Straus J, Marnocha R, Liu G. Attia S, et al. Clin Cancer Res. 2008 Apr 15;14(8):2437-43. doi: 10.1158/1078-0432.CCR-07-4274. Clin Cancer Res. 2008. PMID: 18413835 Free PMC article. Clinical Trial.
141 results